LCN2 and metabolic dysfunction-associated steatotic liver disease: Further studies focusing on the mechanisms underlying fructose-induced pathogenesis of NAFLD, the biological functions of LCN2, and the modulation of these processes by estrogen could potentially lead to novel treatment strategies that will help to decrease the number of patients suffering from elevated hepatic fat deposition and other fat-related disorders.